Levodopa (Larodopa). For the relief of symptoms associated with Parkinson's disease and syndrome.
D000818:Animals; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D004285:Dogs; D005260:Female; D006801:Humans; D051379:Mice; D010300:Parkinson Disease / Q000188:drug therapy*; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D013237:Stereoisomerism
D004295:Dihydroxyphenylalanine